Werewolf Therapeutics, Inc.HOWLNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank50
3Y CAGR-5.8%
5Y CAGR+25.6%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-5.8%/yr
Annual compound
5Y CAGR
+25.6%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
3.1x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$17.98M-5.6%
2024$19.05M+2.0%
2023$18.67M-13.2%
2022$21.50M+45.1%
2021$14.82M+157.1%
2020$5.76M+60.3%
2019$3.60M-